Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form
As of April 1st VIVO Scientific Profiles will no longer updated for faculty, and the link to VIVO will be removed from the library website. Faculty profile pages will continue to be updated via Interfolio. VIVO will continue being used behind the scenes to update graduate student profiles. Please contact helplib@scripps.edu if you have questions.
How to download citations from VIVO | Alternative profile options

Direct adenoviral transfer of bone morphogenetic protein-2 cdna enhances fracture healing in osteoporotic sheep

Academic Article
uri icon
  • Overview
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Egermann, M.
  • Baltzer, A. W.
  • Adamaszek, S.
  • Evans, C.
  • Robbins, Paul D.
  • Schneider, E.
  • Lill, C. A.

publication date

  • May 2006

journal

  • Human Gene Therapy  Journal

abstract

  • Osteoporosis, a major public health burden, is associated with increased fracture risk. Fracture healing in osteoporosis is delayed, with reduced callus formation and impaired biomechanical properties of newly formed bone leading to high risk of fixation failure. Adenoviral gene transfer of bone morphogenetic protein-2 (BMP-2) has been shown to enhance fracture healing. This study evaluated the ability of gene transfer to enhance bone healing in osteoporosis. An established sheep model of osteoporosis with well-characterized alterations in fracture healing was used. Osteotomies were created surgically in the tibias of adult female sheep and monitored for 8 weeks, using radiographic, biomechanical, and histological methods. For pilot experiments, primary ovine osteoblasts and mesenchymal stem cells were transduced with a recombinant adenovirus carrying BMP-2 cDNA (Ad.BMP-2). Large increases in alkaline phosphatase production and mineralization confirmed the ability of human BMP-2 to stimulate osteoblastic differentiation in sheep. In vivo bending stiffness measurements during fracture healing as well as ex vivo torsional stiffness measurements demonstrated stiffer callus tissue after treatment with Ad.BMP-2. The differences were found mainly in the early fracture-healing period. Computed tomography demonstrated that animals receiving the BMP-2 cDNA had larger cross-sectional callus area and higher callus density. Histological examination of the tibias confirmed enhanced callus formation. Direct, local adenoviral delivery of an osteogenic gene thus led to enhanced healing of fractures in an ovine model of osteoporosis. These promising data encourage the further development of genetic approaches to enhance bone healing in patients suffering osteoporosis-associated fractures.

subject areas

  • Adenoviridae
  • Animals
  • Bone Morphogenetic Protein 2
  • Bone Morphogenetic Proteins
  • Bony Callus
  • Cell Differentiation
  • Cells, Cultured
  • Female
  • Fracture Healing
  • Genetic Therapy
  • Genetic Vectors
  • Humans
  • Osteoblasts
  • Osteoporosis
  • Pilot Projects
  • Pliability
  • Radiography
  • Sheep
  • Tibia
  • Transduction, Genetic
  • Transforming Growth Factor beta
scroll to property group menus

Identity

International Standard Serial Number (ISSN)

  • 1043-0342

Digital Object Identifier (DOI)

  • 10.1089/hum.2006.17.507

PubMed ID

  • 16716108
scroll to property group menus

Additional Document Info

start page

  • 507

end page

  • 517

volume

  • 17

issue

  • 5

©2022 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support